Bolsa PT - Gráfico 6 Meses e Resumo de Sepracor Inc. [SEPR]

Sepracor Inc. - [Ticker: SEPR]
Última Trade		Range 52 Semanas	[0,000 - 0,000]
Hora da Última Trade	N/A - N/A	Price-Target 1 Ano	N/A
Variação	()	Capitalização Bolsista	3
Bid / Ask	N/A	EPS	0,00
Abertura		PER	12,69%
Máximo		Pagamento Dividendo	N/A
Mínimo		Data Ex-Dividendo	N/A
Fecho Anterior	0,000	Yield	N/A
Volume		Volume Médio (3m)	0
Nota: Os dados podem apresentar atraso de alguns minutos.

Ver cotações de outros activos

Intraday 5 dias 1 mes 3 meses 6 meses 1 ano 2 anos 5 anos 10 anos Use este gráfico no seu website!
Gráfico de Sepracor Inc. - [Ticker: SEPR]

Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:

Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

Notícias sobre Sepracor Inc. [SEPR]: (ordenadas por relevância)

Drugmakers Duped Medicaid Rebate Regulators, 3rd Circ. Told
Law360
Streck served as a relator under the qui tam provision of the FCA on behalf of the federal government, 23 states and Washington, D.C., court records show. In addition to Allergan, AstraZeneca and NovoNordisk, the defendants included Amgen Inc., Biogen ...

e mais »

Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Previously, Mr. Trachtenberg served in similar capacities for Pozen Inc., Aralez's predecessor, which he joined in June 2015. Mr. Trachtenberg formerly served as Deputy General Counsel at Auxilium Pharmaceuticals, Inc., from 2012 through its ...

e mais »

Form PRE 14A GI DYNAMICS, INC. For: May 21
StreetInsider.com
GI DYNAMICS, INC. PO Box 51915. Boston, MA 02205. May 1, 2018. Dear Stockholder: You are cordially invited to attend the 2018 annual meeting of stockholders of GI Dynamics, Inc. (the ?Annual Meeting?), to be held on May 21, 2018, at 6:00 p.m., United ...

e mais »

Allergy Treatment Market ? Evolving Industry Trends and Key Insights by 2024
Chicago Evening Post
Some of the major market companies in global allergy treatment market are Allergopharma, Allergy Therapeutics, Alerpharma S.A, Allergon AB, Genentech Inc., Allergan, Inc., McNeil Consumer Healthcare, Schering-Plough Corporation, Meda Pharmaceuticals ...

e mais »

Asthma Medication Market Overview, Top Manufactures, Market Size, Industry Growth Analysis & Forecast: 2022
Pharmaceuticals News
Asthma Medication Market is a comprehensive analysis of report provides detailed overview of major challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue and share ...

United States Asthma Medication Market Analysis Report 2018-2025
Facts of Week
United States Asthma Medication market competition by top manufacturers/players, with Asthma Medication sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Dulera, QVAR, Glaxosmithkline ...

e mais »

LANews By Abhishek Budholiya (press release) (blog)

Upcoming Market Forecast Study to Assess the Expansion of Allergy Treatment Market for 2016-2026 Period
LANews By Abhishek Budholiya (press release) (blog)
Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical ...

e mais »

Allergy Treatment Market Forecast By End-use Industry 2016-2026
Facts of Week
Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical ...

e mais »

Bellicum Pharmaceuticals Appoints Edmund P. Harrigan, MD to its Board of Directors
GlobeNewswire (press release)
In addition to his experience at Pfizer, Dr. Harrigan previously served as President & CEO of Karuna Pharmaceuticals, and in senior clinical leadership positions at Neurogen Corp. and Sepracor, Inc. Prior to entering the pharmaceutical industry in 1990 ...

e mais »

Business Wire (press release)

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ...
Business Wire (press release)
Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma. Dr. Abella ...

e mais »

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
Prior to joining Dyax, Todd was at Sunovion Pharmaceuticals, Inc. (previously Sepracor Inc., prior to its acquisition by Sumitomo Dainippon Pharma Co., Ltd), where he served in several roles of increasing responsibility including Vice President ...

e mais »

Spero Announces Appointment of David P. Southwell to its Board of Directors
GlobeNewswire (press release)
CAMBRIDGE, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant bacterial ...

e mais »

The Boston Globe

Japanese executives ponder investing in Mass.
The Boston Globe
They visited a giant laboratory in Cambridge shared by emerging biotech companies and walked the life sciences mecca that is Kendall Square. They met with government officials who want to lure foreign companies to Massachusetts. They even saw the New ...

GlobeNewswire (press release)

ContraFect Appoints Lisa Ricciardi as Chief Operating Officer
GlobeNewswire (press release)
Ms. Ricciardi currently serves on the board United Drug Healthcare Group, PLC, and was a prior board member Chimerix Inc. as well as Sepracor Inc., which was sold to Dainippon Sumitomo for $2.6 billion. About ContraFect: ContraFect is a biotechnology ...

e mais »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of ...

e mais »

Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.